Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale

Parkinsonism and Related Disorders

Volumn 21, Issue 1, 2015, Pages 50-54

  Martínez Martín, Pablo ^a   Rodríguez Blázquez, Carmen ^a   Alvarez, M ^b   Arakaki, Tomoko ^c   Arillo, Víctor Campos ^d   Chaná, Pedro ^e   Fernández, William ^f   Garretto, Nélida ^c   Martínez Castrillo, Juan Carlos ^g   Rodríguez Violante, Mayela ^h   Serrano Dueñas, Marcos ⁱ   Ballesteros, Diego ^j   Rojo Abuin, Jose Manuel ^k   Chaudhuri, Kallol Ray ^l   Merello, Marcelo ^j  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d Movement Disorders Unit Department of Neuroscience Hospital Xanit International Benalmádena ^*  (Spain)

^e UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^f UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

ⁱ PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

^j Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^k CSIC   (Spain)

^l KING S COLLEGE HOSPITAL   (United Kingdom)

more..

Author keywords

Assessment; MDS UPDRS; Parkinson's disease; Severity; Staging

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL IMPRESSION FOR SEVERITY INDEX; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARKINSON DISEASE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; UNIFIED PARKINSON DISEASE RATING SCALE; ADOLESCENT; CLINICAL TRIAL; DISABILITY; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTICENTER STUDY; OBSERVATION; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; OBSERVATION; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84918574785     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.10.026     Document Type: Article

References (22)

1. Hely M.A., Reid W.G., Adena M.A., Halliday G.M., Morris J.G. The Sydney multicentre study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008, 23:837-844.
2. Coelho M., Ferreira J.J. Late-stage Parkinson disease. Nat Rev Neurol 2012, 8:435-442.
3. Stern M.B., Lang A., Poewe W. Toward a redefinition of Parkinson's disease. Mov Disord 2012, 27:54-60.
4. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
5. Goetz C.G., Tilley B.C., Shaftman S.R., Stebbins G.T., Fahn S., Martinez-Martin P., et al. Movement disorders society sponsored revision of the unified Parkinson's disease rating scale: scale presentation and clinimetric testing results. Mov Disord 2008, 23:2129-2170.
6. Chaudhuri K.R., Martinez-Martin P., Brown R.G., Sethi K., Stocchi F., Odin P., et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007, 22:1901-1911.
7. Brown R.G., Dittner A., Findley L., Wessely S.C. The Parkinson fatigue scale. Park Relat Disord 2005, 11:49-55.
8. Katzenschlager R., Schrag A., Evans A., Manson A., Carroll C.B., Ottaviani D., et al. Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure. Neurology 2007, 69:555-563.
9. Ray Chaudhuri K., Rojo J.M., Schapira A.H.V., Brooks D.J., Stocchi F., Odin P., et al. Aproposal for a comprehensive grading of Parkinson's disease severity combining motor and non-motor assessments: meeting an unmet need. PLoS ONE 2013, 8:e57221.
10. Goetz C.G., Poewe W., Rascol O., Sampaio C., Stebbins G.T., Counsell C., et al. Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004, 19:1020-1028.
11. ECDEU assessment manual for psychopharmacology 1976, US Department of Health, Education and Welfare, Public Health Service Alcohol, Drug Abuse, and Mental Health Administration, Rockville, MD. W. Guy (Ed.).
12. Forkmann T., Scherer A., Boecker M., Pawelzik M., Jostes R., Gauggel S. The clinical global impression scale and the influence of patient or staff perspective on outcome. BMC Psychiatry 2011, 11:83.
13. Martinez-Martin P., Forjaz M.J., Cubo E., Frades B., de Pedro Cuesta J. Global versus factor-related impression of severity in Parkinson's disease: a new clinimetric index (CISI-PD). Mov Disord 2006, 21:208-214. The ELEP project members.
14. Lees A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373:2055-2066.
15. Martinez-Martin P., Rodriguez-Blazquez C., Alvarez-Sanchez M., Arakaki T., Bergareche-Yarza A., Chade A., et al. Expanded and independent validation of the movement disorder society-unified Parkinson's disease rating scale (MDS-UPDRS). JNeurol 2013, 260:228-236.
16. Martínez-Martín P., Rodríguez-Blázquez C., Forjaz M.J., de Pedro J. The clinical impression of severity Index for Parkinson's disease: international validation study. Mov Disord 2009, 24:211-217. On behalf of the Spanish-American Longitudinal PD Patient Study Group.
17. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010, 25:2649-2653.
18. Armañanzas R., Bielza C., Chaudhuri K.R., Martinez-Martin P., Larrañaga P. Unveiling relevant non-motor Parkinson's disease severity symptoms using a machine learning approach. Artif Intell Med 2013, 58:195-202.
19. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease The unified Parkinson's disease rating scale (UPDRS): status and recommendations. Mov Disord 2003, 18:738-750.
20. Lang A., Houeto J.L., Krack P., Kubu C., Lyons K.E., Moro E., et al. Deep brain stimulation. Preoperative issues. Mov Disord 2006, 21(Suppl.14):S171-S196.
21. Revicki D., Hays R.D., Cella D., Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. JClin Epidemiol 2008, 61:102-109.
22. Wyrwich K.W., Metz S.M., Kroenke K., Tierney W.M., Babu A.N., Wolinsky F.D. Triangulating patient and clinician perspectives on clinically important differences in health-related quality of life among patients with heart disease. Health Serv Res 2007, 42:2257-2274.